Protective Effects of Recombinant Human Soluble Thrombomodulin on Lipopolysaccharide-Induced Acute Kidney Injury
Thrombomodulin (TM) is a single transmembrane, multidomain glycoprotein receptor for thrombin, and is best known for its role as a cofactor in a clinically important natural anticoagulant pathway. In addition to its anticoagulant function, TM has well-defined anti-inflammatory properties. Soluble TM...
Main Authors: | Yuji Nozaki, Jinhai Ri, Kenji Sakai, Kaoru Niki, Masanori Funauchi, Itaru Matsumura |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2020-04-01
|
Series: | International Journal of Molecular Sciences |
Subjects: | |
Online Access: | https://www.mdpi.com/1422-0067/21/7/2519 |
Similar Items
-
Lipopolysaccharide-Induced Acute Kidney Injury Is Dependent on an IL-18 Receptor Signaling Pathway
by: Yuji Nozaki, et al.
Published: (2017-12-01) -
Markers of acute kidney injury in patients with sepsis: the role of soluble thrombomodulin
by: Shinshu Katayama, et al.
Published: (2017-08-01) -
The effect of recombinant human soluble thrombomodulin on renal function and mortality in septic disseminated intravascular coagulation patients with acute kidney injury: a retrospective study
by: Masayuki Akatsuka, et al.
Published: (2020-12-01) -
Circulating activated protein C levels are not increased in septic patients treated with recombinant human soluble thrombomodulin
by: Takuro Arishima, et al.
Published: (2018-09-01) -
Recombinant human soluble thrombomodulin improves mortality in patients with sepsis especially for severe coagulopathy: a retrospective study
by: Takahiro Kato, et al.
Published: (2018-08-01)